Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-26 Sale |
2022-09-28 5:08 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
1,544 | $15.45 | $23,854 | 62,811 (Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 4:59 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
4,425 | $15.1 | $66,838 | 215,422 (Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 4:57 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
4,280 | $15.08 | $64,560 | 70,905 (Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 4:55 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
4,293 | $15.11 | $64,878 | 64,355 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-19 4:35 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
200 | $15.04 | $3,008 | 219,847 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-19 4:34 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
100 | $15.01 | $1,501 | 68,648 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-19 4:32 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
106 | $15.01 | $1,591 | 49,621 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 4:21 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
1,788 | $15.12 | $27,039 | 220,047 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 4:18 pm |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
2,021 | $15.11 | $30,531 | 79,538 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 4:14 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
1,777 | $15.11 | $26,845 | 68,748 (Direct) |
View |
| 2022-08-29 Sale |
2022-08-31 4:55 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,000 | $12.72 | $25,435 | 206,710 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 4:06 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
4,669 | $13.78 | $64,362 | 119,793 (Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 6:28 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
11,655 | $13.08 | $152,432 | 347,233 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 6:53 pm |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
600 | $13.02 | $7,814 | 368,209 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-29 4:03 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
2,000 | $12 | $24,000 | 208,710 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 4:02 pm |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
7,714 | $13 | $100,282 | 64,893 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 4:02 pm |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
4,000 | $12 | $48,000 | 210,710 (Direct) |
View |
| 2022-06-02 Purchase |
2022-06-06 5:07 pm |
Entrada Therapeutics Inc. | TRDA | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner |
40,947 | $6.3682 | $260,760 | 4,501,658 (Indirect) |
View |
| 2022-05-20 Purchase |
2022-05-24 6:39 pm |
Entrada Therapeutics Inc. | TRDA | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner |
48,509 | $5.8226 | $282,447 | 4,465,029 (Indirect) |
View |
| 2022-05-16 Purchase |
2022-05-18 5:38 pm |
Entrada Therapeutics Inc. | TRDA | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner |
71,944 | $5.9866 | $430,701 | 4,421,689 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-21 Exercise |
2022-09-23 4:57 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
4,280 | $0 | 70,905 (Direct) |
View |
| 2022-09-21 Exercise |
2022-09-23 4:57 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
4,280 | $2.1 | 70,905 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-19 4:32 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
106 | $0 | 49,621 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-19 4:32 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
106 | $2.1 | 49,621 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 4:18 pm |
N/A 2030-12-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
2,021 | $0 | 79,538 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 4:18 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
2,021 | $2.1 | 79,538 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:34 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
5,503 | $0 | 16,489 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:33 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
5,794 | $0 | 162,144 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:32 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
5,172 | $0 | 20,716 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:32 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
5,632 | $0 | 70,525 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:31 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
15,125 | $0 | 221,835 (Direct) |
View |
| 2022-08-24 Exercise |
2022-08-26 4:06 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
1,117 | $0 | 119,793 (Direct) |
View |
| 2022-08-24 Exercise |
2022-08-26 4:06 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
1,117 | $2.1 | 119,793 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 6:28 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
5,972 | $0 | 347,233 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 6:28 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
5,972 | $2.1 | 347,233 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 6:53 pm |
N/A 2030-11-10 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
300 | $0 | 368,209 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 6:53 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
300 | $2.1 | 368,209 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:20 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
33,019 | $0 | 33,019 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:19 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
31,032 | $0 | 31,032 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:18 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
33,788 | $0 | 33,788 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:16 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
34,763 | $0 | 34,763 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO |
90,750 | $0 | 90,750 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:11 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | Foley Todd Director 10% Owner |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:02 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | KIM PETER S Director |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:02 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | Thistle Mary Director |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:01 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:01 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | Crowley John F Director |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:01 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | Nuechterlein Carole Director |
11,918 | $0 | 11,918 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:11 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer |
78,838 | $0 | 140,182 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:10 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer |
81,113 | $0 | 225,875 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:09 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer |
72,407 | $0 | 77,607 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:09 pm |
N/A 2032-03-01 |
Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer |
77,044 | $0 | 86,579 (Direct) |
View |